期刊文献+

环介导等温扩增法检测尿液特异基因DD3诊断前列腺癌的价值

Value of Urine Idio-genes DD3 Detected by Loop-Mediated Isothermal Amplification in Diagnosis of Prostate Cancer
下载PDF
导出
摘要 目的探讨尿液特异基因DD3检测在前列腺癌(prostate cancer,PCa)诊断中的应用价值。方法选择血清前列腺特异性抗原(PSA)异常患者80例,均行前列腺穿刺活检,诊断为前列腺癌27例,前列腺增生53例。留取患者前列腺按摩后尿液。另留取20例健康者尿液作为正常对照。使用环介导等温扩增技术(loop-mediated isothermal amplification,LAMP)检测受试者尿液中DD3表达,并将结果与前列腺穿刺活检结果进行对比。结果前列腺癌患者尿液DD3均阳性表达,前列腺增生患者中仅1例DD3阳性表达,正常对照组DD3均阴性。结论 LAMP法检测尿液DD3与病理检测结果具有较高的一致性,且方法简单、快捷,对前列腺癌诊断具有重要的价值。 Objective To explore the application value in diagnosis of prostate cancer by testing the specific DD3 mRNA in urine. Methods A total of 80 patients with abnormal prostate specific antigen (PSA) in blood serum underwent prostate puncture biopsy, and 27 patients were diagnosed as having PCa, and 53 patients were diagnosed as having benign prostatic hyperplasia (BPH). Patients'urine samples were collected after prostate chirapsia. In addition, 20 urine samples from healthy people were collected as the control group. DD3 expressions in urine from subjects were detected with loop-mediated isothermal amplification (LAMP) technique, and the results were compared with that of prostate biopsy. Results The DD3 examinations revealed positive expression in all urine samples from patients with PCa, a urine sample from patient with BPH, and in control group, urine samples were all negative expressions. Conclusion The results by LAMP in detection of DD3 in urine samples are highly consistent with the results of prostate biopsy. This method is important for diagnosis of prostatc cancer.
出处 《临床误诊误治》 2013年第4期94-96,共3页 Clinical Misdiagnosis & Mistherapy
基金 国家自然基金课题(81070597) 南京市医学科技发展重点项目(ZKX09003)
关键词 环介导等温扩增 前列腺肿瘤 尿 前列腺癌特异基因3 LAMP Prostate cancer Urine Prostate cancer idio-genes 3
  • 相关文献

参考文献13

  • 1李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:170
  • 2Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008 [J]. CA Cancer J Clin, 2008,58(2) :71-96.
  • 3Bussemakers M J, van Bokhoven A, Verhaegh G W, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer[J]. Cancer Res, 1999,59(23) :5975-5979.
  • 4Mistry K, Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma[J]. J Am Board Fam Pract, 2003,16(2) :95-101.
  • 5Hessels D, Klein Gunnewiek J M, van Oort I, et al. DD3 (PCA3)-based molecular urine analysis for the diagnosis of prostate cancer [J]. Eur Urol, 2003 ,dd ( 1 ) :8-15.
  • 6de Kok J B, Verhaegh G W, Roelofs R W, et al. DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors [ J 1. Cancer Res, 2002,62 ( 9 ) :2695-2698.
  • 7Hessels D, Verhaegh G W, Schalken J A, et al. Applica- bility of biomarkers in the early diagnosis of prostate cancer [J]. Expert Rev Mol Diagn, 2004,4(4) :513-526.
  • 8van Gi|s M P, Cornel E B, Hessels D, et al. Molecular PCA3 diagnostics on prostatic fluid [ J ]. Prostate, 2007,67 (8) :881-887.
  • 9Mearini E, Antognelli C, Del C, et al. The combination of urine DD3 (PCA3) mRNA and PSA mRNA as molecular mark- ers of prostate cancer [ J ]. Biomarkers, 2009,14 (4) :235-243.
  • 10Hill J, Beriwal S, Chandra I, et al. Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli[J]. J Clin Microbiol, 2008,46(8):2800-2804.

二级参考文献14

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献169

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部